These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25875698)

  • 1. Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.
    Scarselli A; Di Cesare S; Capponi C; Cascioli S; Romiti ML; Di Matteo G; Simonetti A; Palma P; Finocchi A; Lucarelli B; Pinto RM; Rana I; Palumbo G; Caniglia M; Rossi P; Carsetti R; Cancrini C; Aiuti A
    J Clin Immunol; 2015 May; 35(4):373-83. PubMed ID: 25875698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
    Knutsen AP; Wall DA
    J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
    Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
    J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
    Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
    Front Immunol; 2019; 10():1879. PubMed ID: 31507582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplantation cyclophosphamide mediates effective reconstitution of memory B cells after allogeneic hematopoietic cell transplantation.
    Hayashi T; Nakashima Y; Takeda S; Nishimoto M; Okamura H; Takakuwa T; Kuno M; Makuuchi Y; Ido K; Sakatoku K; Horiuchi M; Koh H; Nakamae M; Hino M; Nakamae H
    Eur J Haematol; 2024 Nov; 113(5):651-663. PubMed ID: 39072897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
    Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
    J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients.
    Marasco E; Farroni C; Cascioli S; Marcellini V; Scarsella M; Giorda E; Piano Mortari E; Leonardi L; Scarselli A; Valentini D; Cancrini C; Duse M; Grimsholm O; Carsetti R
    Eur J Immunol; 2017 Jan; 47(1):131-143. PubMed ID: 27800605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
    Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
    J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
    Al-Herz W; Chu JI; van der Spek J; Raghupathy R; Massaad MJ; Keles S; Biggs CM; Cockerton L; Chou J; Dbaibo G; Elisofon SA; Hanna-Wakim R; Kim HB; Lehmann LE; McDonald DR; Notarangelo LD; Veys P; Chatila TA; Geha RS; Gaspar HB; Pai SY
    J Allergy Clin Immunol; 2016 Sep; 138(3):852-859.e3. PubMed ID: 27130861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency.
    Bhattacharya A; Slatter MA; Chapman CE; Barge D; Jackson A; Flood TJ; Abinun M; Cant AJ; Gennery AR
    Bone Marrow Transplant; 2005 Aug; 36(4):295-9. PubMed ID: 15968287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency.
    Slatter MA; Bhattacharya A; Abinun M; Flood TJ; Cant AJ; Gennery AR
    Bone Marrow Transplant; 2005 Apr; 35(7):683-9. PubMed ID: 15723084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab.
    Kennedy VE; Sahaf B; Wu F; Ehlinger ZJ; Arai S; Miklos DB
    Transplant Cell Ther; 2024 May; 30(5):518.e1-518.e13. PubMed ID: 38458479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of immune reconstitution in children undergoing cord blood transplantation.
    Moretta A; Maccario R; Fagioli F; Giraldi E; Busca A; Montagna D; Miniero R; Comoli P; Giorgiani G; Zecca M; Pagani S; Locatelli F
    Exp Hematol; 2001 Mar; 29(3):371-9. PubMed ID: 11274766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.